Screening Strategies for COVID-19 in Patients With Hematologic Malignancies.
Identifieur interne : 000646 ( Main/Exploration ); précédent : 000645; suivant : 000647Screening Strategies for COVID-19 in Patients With Hematologic Malignancies.
Auteurs : Tarek Assi [Liban] ; Bachar Samra [États-Unis] ; Laurent Dercle [États-Unis] ; Elie Rassy [Liban] ; Joseph Kattan [Liban] ; Marwan Ghosn [Liban] ; Roch Houot [France, États-Unis] ; Samy Ammari [France]Source :
- Frontiers in oncology [ 2234-943X ] ; 2020.
Abstract
COVID-19 has been declared a pandemic by the world health organization. Patients with cancer, and particularly hematologic malignancies may be at higher risk for severe complications due to their malignancy, immune dysregulation, therapy, and associated comorbidities. The oncology community has been proactive in issuing practice guidelines to help optimize management, and limit infection risk and complications from SARS-COV-2. Although hematologic malignancies account for only 10% of all cancers, their management is particularly complex, especially in the time of COVID-19. Screening or early detection of COVID-19 are central for preventative/mitigation strategy, which is the best current strategy in our battle against COVID-19. Herein, we provide an overview of COVID-19 screening strategies and highlight the unique aspects of treating patients with hematologic malignancies.
DOI: 10.3389/fonc.2020.01267
PubMed: 32719749
PubMed Central: PMC7348065
Affiliations:
- France, Liban, États-Unis
- Massachusetts, Région Bretagne, Texas, État de New York, Île-de-France
- Paris, Rennes, Villejuif
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Screening Strategies for COVID-19 in Patients With Hematologic Malignancies.</title><author><name sortKey="Assi, Tarek" sort="Assi, Tarek" uniqKey="Assi T" first="Tarek" last="Assi">Tarek Assi</name><affiliation wicri:level="1"><nlm:affiliation>Department of Hematology and Medical Oncology, Faculty of Medicine, Saint-Joseph University, Beirut, Lebanon.</nlm:affiliation><country xml:lang="fr">Liban</country><wicri:regionArea>Department of Hematology and Medical Oncology, Faculty of Medicine, Saint-Joseph University, Beirut</wicri:regionArea><wicri:noRegion>Beirut</wicri:noRegion></affiliation></author><author><name sortKey="Samra, Bachar" sort="Samra, Bachar" uniqKey="Samra B" first="Bachar" last="Samra">Bachar Samra</name><affiliation wicri:level="2"><nlm:affiliation>Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX</wicri:regionArea><placeName><region type="state">Texas</region></placeName></affiliation></author><author><name sortKey="Dercle, Laurent" sort="Dercle, Laurent" uniqKey="Dercle L" first="Laurent" last="Dercle">Laurent Dercle</name><affiliation wicri:level="2"><nlm:affiliation>Radiology Department, Columbia University Medical Center, New York Presbyterian Hospital, New York, NY, United States.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Radiology Department, Columbia University Medical Center, New York Presbyterian Hospital, New York, NY</wicri:regionArea><placeName><region type="state">État de New York</region></placeName></affiliation></author><author><name sortKey="Rassy, Elie" sort="Rassy, Elie" uniqKey="Rassy E" first="Elie" last="Rassy">Elie Rassy</name><affiliation wicri:level="1"><nlm:affiliation>Department of Hematology and Medical Oncology, Faculty of Medicine, Saint-Joseph University, Beirut, Lebanon.</nlm:affiliation><country xml:lang="fr">Liban</country><wicri:regionArea>Department of Hematology and Medical Oncology, Faculty of Medicine, Saint-Joseph University, Beirut</wicri:regionArea><wicri:noRegion>Beirut</wicri:noRegion></affiliation></author><author><name sortKey="Kattan, Joseph" sort="Kattan, Joseph" uniqKey="Kattan J" first="Joseph" last="Kattan">Joseph Kattan</name><affiliation wicri:level="1"><nlm:affiliation>Department of Hematology and Medical Oncology, Faculty of Medicine, Saint-Joseph University, Beirut, Lebanon.</nlm:affiliation><country xml:lang="fr">Liban</country><wicri:regionArea>Department of Hematology and Medical Oncology, Faculty of Medicine, Saint-Joseph University, Beirut</wicri:regionArea><wicri:noRegion>Beirut</wicri:noRegion></affiliation></author><author><name sortKey="Ghosn, Marwan" sort="Ghosn, Marwan" uniqKey="Ghosn M" first="Marwan" last="Ghosn">Marwan Ghosn</name><affiliation wicri:level="1"><nlm:affiliation>Department of Hematology and Medical Oncology, Faculty of Medicine, Saint-Joseph University, Beirut, Lebanon.</nlm:affiliation><country xml:lang="fr">Liban</country><wicri:regionArea>Department of Hematology and Medical Oncology, Faculty of Medicine, Saint-Joseph University, Beirut</wicri:regionArea><wicri:noRegion>Beirut</wicri:noRegion></affiliation></author><author><name sortKey="Houot, Roch" sort="Houot, Roch" uniqKey="Houot R" first="Roch" last="Houot">Roch Houot</name><affiliation wicri:level="3"><nlm:affiliation>Department of Hematology, CHU de Rennes, Université de Rennes, Rennes, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Department of Hematology, CHU de Rennes, Université de Rennes, Rennes</wicri:regionArea><placeName><region type="region">Région Bretagne</region><region type="old region">Région Bretagne</region><settlement type="city">Rennes</settlement></placeName></affiliation><affiliation wicri:level="2"><nlm:affiliation>Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA</wicri:regionArea><placeName><region type="state">Massachusetts</region></placeName></affiliation></author><author><name sortKey="Ammari, Samy" sort="Ammari, Samy" uniqKey="Ammari S" first="Samy" last="Ammari">Samy Ammari</name><affiliation wicri:level="3"><nlm:affiliation>Radiology Department, Gustave Roussy Cancer Campus, Villejuif, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Radiology Department, Gustave Roussy Cancer Campus, Villejuif</wicri:regionArea><placeName><settlement type="city">Villejuif</settlement></placeName></affiliation><affiliation wicri:level="3"><nlm:affiliation>BIOMAPS, UMR1281, INSERM.CEA.CNRS, Université Paris-Saclay, Paris, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>BIOMAPS, UMR1281, INSERM.CEA.CNRS, Université Paris-Saclay, Paris</wicri:regionArea><placeName><region type="region">Île-de-France</region><region type="old region">Île-de-France</region><settlement type="city">Paris</settlement></placeName></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2020">2020</date><idno type="RBID">pubmed:32719749</idno><idno type="pmid">32719749</idno><idno type="doi">10.3389/fonc.2020.01267</idno><idno type="pmc">PMC7348065</idno><idno type="wicri:Area/Main/Corpus">000820</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000820</idno><idno type="wicri:Area/Main/Curation">000820</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000820</idno><idno type="wicri:Area/Main/Exploration">000820</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Screening Strategies for COVID-19 in Patients With Hematologic Malignancies.</title><author><name sortKey="Assi, Tarek" sort="Assi, Tarek" uniqKey="Assi T" first="Tarek" last="Assi">Tarek Assi</name><affiliation wicri:level="1"><nlm:affiliation>Department of Hematology and Medical Oncology, Faculty of Medicine, Saint-Joseph University, Beirut, Lebanon.</nlm:affiliation><country xml:lang="fr">Liban</country><wicri:regionArea>Department of Hematology and Medical Oncology, Faculty of Medicine, Saint-Joseph University, Beirut</wicri:regionArea><wicri:noRegion>Beirut</wicri:noRegion></affiliation></author><author><name sortKey="Samra, Bachar" sort="Samra, Bachar" uniqKey="Samra B" first="Bachar" last="Samra">Bachar Samra</name><affiliation wicri:level="2"><nlm:affiliation>Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX</wicri:regionArea><placeName><region type="state">Texas</region></placeName></affiliation></author><author><name sortKey="Dercle, Laurent" sort="Dercle, Laurent" uniqKey="Dercle L" first="Laurent" last="Dercle">Laurent Dercle</name><affiliation wicri:level="2"><nlm:affiliation>Radiology Department, Columbia University Medical Center, New York Presbyterian Hospital, New York, NY, United States.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Radiology Department, Columbia University Medical Center, New York Presbyterian Hospital, New York, NY</wicri:regionArea><placeName><region type="state">État de New York</region></placeName></affiliation></author><author><name sortKey="Rassy, Elie" sort="Rassy, Elie" uniqKey="Rassy E" first="Elie" last="Rassy">Elie Rassy</name><affiliation wicri:level="1"><nlm:affiliation>Department of Hematology and Medical Oncology, Faculty of Medicine, Saint-Joseph University, Beirut, Lebanon.</nlm:affiliation><country xml:lang="fr">Liban</country><wicri:regionArea>Department of Hematology and Medical Oncology, Faculty of Medicine, Saint-Joseph University, Beirut</wicri:regionArea><wicri:noRegion>Beirut</wicri:noRegion></affiliation></author><author><name sortKey="Kattan, Joseph" sort="Kattan, Joseph" uniqKey="Kattan J" first="Joseph" last="Kattan">Joseph Kattan</name><affiliation wicri:level="1"><nlm:affiliation>Department of Hematology and Medical Oncology, Faculty of Medicine, Saint-Joseph University, Beirut, Lebanon.</nlm:affiliation><country xml:lang="fr">Liban</country><wicri:regionArea>Department of Hematology and Medical Oncology, Faculty of Medicine, Saint-Joseph University, Beirut</wicri:regionArea><wicri:noRegion>Beirut</wicri:noRegion></affiliation></author><author><name sortKey="Ghosn, Marwan" sort="Ghosn, Marwan" uniqKey="Ghosn M" first="Marwan" last="Ghosn">Marwan Ghosn</name><affiliation wicri:level="1"><nlm:affiliation>Department of Hematology and Medical Oncology, Faculty of Medicine, Saint-Joseph University, Beirut, Lebanon.</nlm:affiliation><country xml:lang="fr">Liban</country><wicri:regionArea>Department of Hematology and Medical Oncology, Faculty of Medicine, Saint-Joseph University, Beirut</wicri:regionArea><wicri:noRegion>Beirut</wicri:noRegion></affiliation></author><author><name sortKey="Houot, Roch" sort="Houot, Roch" uniqKey="Houot R" first="Roch" last="Houot">Roch Houot</name><affiliation wicri:level="3"><nlm:affiliation>Department of Hematology, CHU de Rennes, Université de Rennes, Rennes, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Department of Hematology, CHU de Rennes, Université de Rennes, Rennes</wicri:regionArea><placeName><region type="region">Région Bretagne</region><region type="old region">Région Bretagne</region><settlement type="city">Rennes</settlement></placeName></affiliation><affiliation wicri:level="2"><nlm:affiliation>Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA</wicri:regionArea><placeName><region type="state">Massachusetts</region></placeName></affiliation></author><author><name sortKey="Ammari, Samy" sort="Ammari, Samy" uniqKey="Ammari S" first="Samy" last="Ammari">Samy Ammari</name><affiliation wicri:level="3"><nlm:affiliation>Radiology Department, Gustave Roussy Cancer Campus, Villejuif, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Radiology Department, Gustave Roussy Cancer Campus, Villejuif</wicri:regionArea><placeName><settlement type="city">Villejuif</settlement></placeName></affiliation><affiliation wicri:level="3"><nlm:affiliation>BIOMAPS, UMR1281, INSERM.CEA.CNRS, Université Paris-Saclay, Paris, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>BIOMAPS, UMR1281, INSERM.CEA.CNRS, Université Paris-Saclay, Paris</wicri:regionArea><placeName><region type="region">Île-de-France</region><region type="old region">Île-de-France</region><settlement type="city">Paris</settlement></placeName></affiliation></author></analytic><series><title level="j">Frontiers in oncology</title><idno type="ISSN">2234-943X</idno><imprint><date when="2020" type="published">2020</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">COVID-19 has been declared a pandemic by the world health organization. Patients with cancer, and particularly hematologic malignancies may be at higher risk for severe complications due to their malignancy, immune dysregulation, therapy, and associated comorbidities. The oncology community has been proactive in issuing practice guidelines to help optimize management, and limit infection risk and complications from SARS-COV-2. Although hematologic malignancies account for only 10% of all cancers, their management is particularly complex, especially in the time of COVID-19. Screening or early detection of COVID-19 are central for preventative/mitigation strategy, which is the best current strategy in our battle against COVID-19. Herein, we provide an overview of COVID-19 screening strategies and highlight the unique aspects of treating patients with hematologic malignancies.</div></front></TEI><pubmed><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">32719749</PMID><DateRevised><Year>2020</Year><Month>07</Month><Day>29</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2234-943X</ISSN><JournalIssue CitedMedium="Print"><Volume>10</Volume><PubDate><Year>2020</Year></PubDate></JournalIssue><Title>Frontiers in oncology</Title><ISOAbbreviation>Front Oncol</ISOAbbreviation></Journal><ArticleTitle>Screening Strategies for COVID-19 in Patients With Hematologic Malignancies.</ArticleTitle><Pagination><MedlinePgn>1267</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3389/fonc.2020.01267</ELocationID><Abstract><AbstractText>COVID-19 has been declared a pandemic by the world health organization. Patients with cancer, and particularly hematologic malignancies may be at higher risk for severe complications due to their malignancy, immune dysregulation, therapy, and associated comorbidities. The oncology community has been proactive in issuing practice guidelines to help optimize management, and limit infection risk and complications from SARS-COV-2. Although hematologic malignancies account for only 10% of all cancers, their management is particularly complex, especially in the time of COVID-19. Screening or early detection of COVID-19 are central for preventative/mitigation strategy, which is the best current strategy in our battle against COVID-19. Herein, we provide an overview of COVID-19 screening strategies and highlight the unique aspects of treating patients with hematologic malignancies.</AbstractText><CopyrightInformation>Copyright © 2020 Assi, Samra, Dercle, Rassy, Kattan, Ghosn, Houot and Ammari.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Assi</LastName><ForeName>Tarek</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Hematology and Medical Oncology, Faculty of Medicine, Saint-Joseph University, Beirut, Lebanon.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Samra</LastName><ForeName>Bachar</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dercle</LastName><ForeName>Laurent</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Radiology Department, Columbia University Medical Center, New York Presbyterian Hospital, New York, NY, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rassy</LastName><ForeName>Elie</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Hematology and Medical Oncology, Faculty of Medicine, Saint-Joseph University, Beirut, Lebanon.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kattan</LastName><ForeName>Joseph</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Hematology and Medical Oncology, Faculty of Medicine, Saint-Joseph University, Beirut, Lebanon.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ghosn</LastName><ForeName>Marwan</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Hematology and Medical Oncology, Faculty of Medicine, Saint-Joseph University, Beirut, Lebanon.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Houot</LastName><ForeName>Roch</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Hematology, CHU de Rennes, Université de Rennes, Rennes, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ammari</LastName><ForeName>Samy</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Radiology Department, Gustave Roussy Cancer Campus, Villejuif, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>BIOMAPS, UMR1281, INSERM.CEA.CNRS, Université Paris-Saclay, Paris, France.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>07</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Oncol</MedlineTA><NlmUniqueID>101568867</NlmUniqueID><ISSNLinking>2234-943X</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">CT scan</Keyword><Keyword MajorTopicYN="N">coronavirus</Keyword><Keyword MajorTopicYN="N">hematologic malignancies</Keyword><Keyword MajorTopicYN="N">hematology</Keyword><Keyword MajorTopicYN="N">polymerase chain reaction</Keyword><Keyword MajorTopicYN="N">screening</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>05</Month><Day>06</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>06</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>7</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>7</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>7</Month><Day>29</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32719749</ArticleId><ArticleId IdType="doi">10.3389/fonc.2020.01267</ArticleId><ArticleId IdType="pmc">PMC7348065</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>J Am Coll Radiol. 2020 Jun;17(6):701-709</Citation><ArticleIdList><ArticleId IdType="pubmed">32283052</ArticleId></ArticleIdList></Reference><Reference><Citation>Med J Aust. 2020 Jun;212(10):481-489</Citation><ArticleIdList><ArticleId IdType="pubmed">32401360</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2020 Feb 20;382(8):727-733</Citation><ArticleIdList><ArticleId IdType="pubmed">31978945</ArticleId></ArticleIdList></Reference><Reference><Citation>Radiology. 2020 Aug;296(2):E72-E78</Citation><ArticleIdList><ArticleId IdType="pubmed">32216717</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2020 Mar 28;395(10229):1054-1062</Citation><ArticleIdList><ArticleId IdType="pubmed">32171076</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Med. 2020 May;26(5):665-671</Citation><ArticleIdList><ArticleId IdType="pubmed">32405058</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Infect Dis. 2013 Jan;56(2):258-66</Citation><ArticleIdList><ArticleId IdType="pubmed">23024295</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE Trans Med Imaging. 2016 May;35(5):1207-1216</Citation><ArticleIdList><ArticleId IdType="pubmed">26955021</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet Oncol. 2020 Mar;21(3):335-337</Citation><ArticleIdList><ArticleId IdType="pubmed">32066541</ArticleId></ArticleIdList></Reference><Reference><Citation>Radiology. 2020 Aug;296(2):E115-E117</Citation><ArticleIdList><ArticleId IdType="pubmed">32073353</ArticleId></ArticleIdList></Reference><Reference><Citation>Oncologist. 2020 Jun;25(6):e936-e945</Citation><ArticleIdList><ArticleId IdType="pubmed">32243668</ArticleId></ArticleIdList></Reference><Reference><Citation>J Geriatr Oncol. 2020 Jun;11(5):764-768</Citation><ArticleIdList><ArticleId IdType="pubmed">32331928</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Oncol. 2020 Jul;31(7):894-901</Citation><ArticleIdList><ArticleId IdType="pubmed">32224151</ArticleId></ArticleIdList></Reference><Reference><Citation>Cancer Discov. 2020 Jun;10(6):783-791</Citation><ArticleIdList><ArticleId IdType="pubmed">32345594</ArticleId></ArticleIdList></Reference><Reference><Citation>Cancer Microenviron. 2011 Dec;4(3):313-23</Citation><ArticleIdList><ArticleId IdType="pubmed">21866321</ArticleId></ArticleIdList></Reference><Reference><Citation>Leuk Res. 2020 Mar 26;92:106353</Citation><ArticleIdList><ArticleId IdType="pubmed">32251934</ArticleId></ArticleIdList></Reference><Reference><Citation>Hematol Transfus Cell Ther. 2020 Apr - Jun;42(2):103-110</Citation><ArticleIdList><ArticleId IdType="pubmed">32313873</ArticleId></ArticleIdList></Reference><Reference><Citation>Radiology. 2020 Aug;296(2):E46-E54</Citation><ArticleIdList><ArticleId IdType="pubmed">32155105</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2020 Feb 15;395(10223):e30-e31</Citation><ArticleIdList><ArticleId IdType="pubmed">32032529</ArticleId></ArticleIdList></Reference><Reference><Citation>Blood. 2020 May 21;135(21):1912-1915</Citation><ArticleIdList><ArticleId IdType="pubmed">32302379</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet Haematol. 2020 Apr;7(4):e351-e352</Citation><ArticleIdList><ArticleId IdType="pubmed">32220344</ArticleId></ArticleIdList></Reference><Reference><Citation>CA Cancer J Clin. 2020 Jan;70(1):7-30</Citation><ArticleIdList><ArticleId IdType="pubmed">31912902</ArticleId></ArticleIdList></Reference><Reference><Citation>Radiology. 2020 Aug;296(2):E65-E71</Citation><ArticleIdList><ArticleId IdType="pubmed">32191588</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Infect Dis. 2020 Jul 28;71(15):778-785</Citation><ArticleIdList><ArticleId IdType="pubmed">32198501</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Haematol. 2016 May;173(3):380-93</Citation><ArticleIdList><ArticleId IdType="pubmed">27060988</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2020 May 28;382(22):2158-2160</Citation><ArticleIdList><ArticleId IdType="pubmed">32329972</ArticleId></ArticleIdList></Reference><Reference><Citation>Acta Haematol. 2020 Apr 17;:1-7</Citation><ArticleIdList><ArticleId IdType="pubmed">32305989</ArticleId></ArticleIdList></Reference><Reference><Citation>Cancer. 1980 Jun 1;45(11):2843-8</Citation><ArticleIdList><ArticleId IdType="pubmed">7379014</ArticleId></ArticleIdList></Reference><Reference><Citation>J Allergy Clin Immunol Pract. 2020 May;8(5):1489-1491</Citation><ArticleIdList><ArticleId IdType="pubmed">32220575</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Oncol. 2020 Feb 10;38(5):415-422</Citation><ArticleIdList><ArticleId IdType="pubmed">31815579</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Acad Dermatol. 2020 Aug;83(2):703-704</Citation><ArticleIdList><ArticleId IdType="pubmed">32305443</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet Infect Dis. 2020 Apr;20(4):398-400</Citation><ArticleIdList><ArticleId IdType="pubmed">32113510</ArticleId></ArticleIdList></Reference><Reference><Citation>BMJ. 2020 Mar 23;368:m1165</Citation><ArticleIdList><ArticleId IdType="pubmed">32205334</ArticleId></ArticleIdList></Reference><Reference><Citation>Hematol Transfus Cell Ther. 2020 Apr - Jun;42(2):111-112</Citation><ArticleIdList><ArticleId IdType="pubmed">32292885</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Haematol. 2020 Apr;189(2):239-240</Citation><ArticleIdList><ArticleId IdType="pubmed">32180224</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE Rev Biomed Eng. 2020 Apr 16;:</Citation><ArticleIdList><ArticleId IdType="pubmed">32305937</ArticleId></ArticleIdList></Reference><Reference><Citation>Radiographics. 2013 Nov-Dec;33(7):1951-75</Citation><ArticleIdList><ArticleId IdType="pubmed">24224590</ArticleId></ArticleIdList></Reference><Reference><Citation>Blood Transfus. 2020 Mar;18(2):77-78</Citation><ArticleIdList><ArticleId IdType="pubmed">32267829</ArticleId></ArticleIdList></Reference><Reference><Citation>Oncotarget. 2017 Jan 10;8(2):3274-3288</Citation><ArticleIdList><ArticleId IdType="pubmed">27906678</ArticleId></ArticleIdList></Reference><Reference><Citation>Johns Hopkins Med J. 1976 Jul;139(1):1-12</Citation><ArticleIdList><ArticleId IdType="pubmed">820917</ArticleId></ArticleIdList></Reference><Reference><Citation>Radiology. 2020 Aug;296(2):E32-E40</Citation><ArticleIdList><ArticleId IdType="pubmed">32101510</ArticleId></ArticleIdList></Reference><Reference><Citation>Blood Adv. 2020 Apr 14;4(7):1307-1310</Citation><ArticleIdList><ArticleId IdType="pubmed">32243501</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA. 2020 Feb 21;:</Citation><ArticleIdList><ArticleId IdType="pubmed">32083643</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Haematol. 2020 Apr;189(2):241-243</Citation><ArticleIdList><ArticleId IdType="pubmed">32173855</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell. 2018 Feb 22;172(5):1122-1131.e9</Citation><ArticleIdList><ArticleId IdType="pubmed">29474911</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2020 Mar 5;382(10):970-971</Citation><ArticleIdList><ArticleId IdType="pubmed">32003551</ArticleId></ArticleIdList></Reference><Reference><Citation>ESMO Open. 2020 Mar;5(2):</Citation><ArticleIdList><ArticleId IdType="pubmed">32229501</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Virol. 2015 Jul;68:1-5</Citation><ArticleIdList><ArticleId IdType="pubmed">26071326</ArticleId></ArticleIdList></Reference><Reference><Citation>AJR Am J Roentgenol. 2020 Apr 16;:1-4</Citation><ArticleIdList><ArticleId IdType="pubmed">32298149</ArticleId></ArticleIdList></Reference><Reference><Citation>Biol Blood Marrow Transplant. 2020 Jul;26(7):1239-1246</Citation><ArticleIdList><ArticleId IdType="pubmed">32298807</ArticleId></ArticleIdList></Reference><Reference><Citation>Pediatr Hematol Oncol. 2011 Apr;28(3):176-86</Citation><ArticleIdList><ArticleId IdType="pubmed">21381869</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></pubmed><affiliations><list><country><li>France</li><li>Liban</li><li>États-Unis</li></country><region><li>Massachusetts</li><li>Région Bretagne</li><li>Texas</li><li>État de New York</li><li>Île-de-France</li></region><settlement><li>Paris</li><li>Rennes</li><li>Villejuif</li></settlement></list><tree><country name="Liban"><noRegion><name sortKey="Assi, Tarek" sort="Assi, Tarek" uniqKey="Assi T" first="Tarek" last="Assi">Tarek Assi</name></noRegion><name sortKey="Ghosn, Marwan" sort="Ghosn, Marwan" uniqKey="Ghosn M" first="Marwan" last="Ghosn">Marwan Ghosn</name><name sortKey="Kattan, Joseph" sort="Kattan, Joseph" uniqKey="Kattan J" first="Joseph" last="Kattan">Joseph Kattan</name><name sortKey="Rassy, Elie" sort="Rassy, Elie" uniqKey="Rassy E" first="Elie" last="Rassy">Elie Rassy</name></country><country name="États-Unis"><region name="Texas"><name sortKey="Samra, Bachar" sort="Samra, Bachar" uniqKey="Samra B" first="Bachar" last="Samra">Bachar Samra</name></region><name sortKey="Dercle, Laurent" sort="Dercle, Laurent" uniqKey="Dercle L" first="Laurent" last="Dercle">Laurent Dercle</name><name sortKey="Houot, Roch" sort="Houot, Roch" uniqKey="Houot R" first="Roch" last="Houot">Roch Houot</name></country><country name="France"><region name="Région Bretagne"><name sortKey="Houot, Roch" sort="Houot, Roch" uniqKey="Houot R" first="Roch" last="Houot">Roch Houot</name></region><name sortKey="Ammari, Samy" sort="Ammari, Samy" uniqKey="Ammari S" first="Samy" last="Ammari">Samy Ammari</name><name sortKey="Ammari, Samy" sort="Ammari, Samy" uniqKey="Ammari S" first="Samy" last="Ammari">Samy Ammari</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidFranceV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000646 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000646 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= CovidFranceV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:32719749
|texte= Screening Strategies for COVID-19 in Patients With Hematologic Malignancies.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:32719749" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a CovidFranceV1
| This area was generated with Dilib version V0.6.37. |  |